DWTX highlights Halneuron potential for chemotherapy-induced neuropathic pain
Halneuron, a selective NaV1.7 inhibitor, is positioned as a first-in-class, durable therapy for chemotherapy-induced neuropathic pain, citing durable efficacy and a strong safety profile in clinical trials.